MedPath

Physica System KR Vs Physica System CR (K-20)

Not Applicable
Terminated
Conditions
Total Knee Replacement
Interventions
Device: Physica Kinematic Retaining knee replacement
Device: Physica Cruciate Retaining knee replacement
Registration Number
NCT04594447
Lead Sponsor
Limacorporate S.p.a
Brief Summary

Post-market, monocentric, randomised, open-label, parallel group, prospective study conducted in patients who have to perform a total knee replacement (TKR) with Physica KR or Physica CR system.

Detailed Description

The aim of the study is to evaluate the clinical, radiographic and PROMs outcomes of Total Knee Arthroplasty (TKA) with 2 Lima TKR design: Physica KR and Physica CR (randomization 1:1) from preoperative to 1-year follow-up.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  1. Males and females of any race requiring a total knee replacement and suitable for the use of one of the two configurations of the Physica system.
  2. Age ≥ 18 years old,
  3. Patients who are suffering from non-inflammatory degenerative joint disease (NIDJD): including knee osteoarthritis, post-traumatic knee arthritis, avascular necrosis; or patient who are suffering from inflammatory joint disease including rheumatoid arthritis.
  4. Suitable candidates for TKR who have undamaged and functional collateral ligaments
  5. Suitable candidates for TKR with Physica KR and CR who have an undamaged and functional posterior cruciate ligament.
  6. Patients who understand the conditions of the study and are willing and able to comply with the prescribed rehabilitation and to perform all scheduled follow-up visits.
  7. Patients who have signed the Ethics Committee/IRB approved study-specific Informed Consent Form prior to the surgery.
Exclusion Criteria
  1. Patients with severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function.
  2. Patients with active or any suspected infection (on the affected knee or systemic)
  3. Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy
  4. Patients with significant bone loss on femoral or tibial joint side
  5. Current treatment for malignant and/or life-threatening nonmalignant disorders
  6. Patients with known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials
  7. Patient with open epiphyses (immature patient with active bone growth).
  8. Vascular insufficiency of lower limbs severe enough to interfere with the study evaluation
  9. Patients with bone stock compromised by disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis
  10. Patients with systemic or metabolic disorders leading to progressive bone deterioration which may impair fixation and stability of the implant
  11. Any concomitant disease and dependence that might affect the performance of the implanted prosthesis
  12. Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation (e.g. primary osteoporosis with significant bone loss, haemophilic disease, septicaemia, persistent acute or chronic osteomyelitis)
  13. Patients who have significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery and evaluation
  14. Patients who have neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device
  15. Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint
  16. Any psychiatric illness that would prevent comprehension of the details and nature of the study
  17. Patients currently participating in any other surgical intervention studies or pain management studies
  18. Female patients who are pregnant, nursing, or planning a pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physica KRPhysica Kinematic Retaining knee replacementSubject that receive Physica Kinematic Retaining total Knee replacement system
Physica CRPhysica Cruciate Retaining knee replacementSubject that receive Physica Cruciate Retaining total Knee replacement system
Primary Outcome Measures
NameTimeMethod
Oxford Knee Score (OKS)Baseline to 1 year FU

Changes of the Oxford Knee Score (OKS) from preoperative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

Specifically designed and developed to assess function and pain after TKR surgery. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.

Secondary Outcome Measures
NameTimeMethod
Range of Motion (ROM)Baseline to 1 year FU

Changes in the Range of Motion (ROM) from pre-operative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

40 metre fast paced walk testBaseline to 1 year FU

Functional changes in 40 metre fast paced walk test from preoperative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

30-second Chair Stand Test (30 CST)Baseline to 1 year FU

Functional changes in 30-second Chair Stand Test (30 CST) from pre-operative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

Serious Adverse Event (SAE) incidenceBaseline to 1 year FU

Changes Incidence, type and severity of all device-related Serious Adverse Events (SAEs) at intra-operatively, at discharge, 6 months and 1 year after the implant.

Medical Outcomes Survey Short Form-36 (SF-36) RAND SF-36Baseline to 1 year FU

Changes in 36-Item Short Form Health Survey (SF-36) outcome from pre-operative (baseline) to 1 year after the implant.

This questionnaire includes 8 scales of differing domains of health: physical functioning, bodily pain, role-physical, general health, vitality, role emotional, social functioning, and mental health. Each scale is scored on a 0 to 100 scale with a 100 representing the best score possible.

Knee Society Score (KSS)Baseline to 1 year FU

Changes in the Knee Society Score (KSS) from pre-operative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

KSS is divided into two components to assess the knee clinically through the physical examination, and to assess the individual's functionality . The maximum score of 100 points that is the best outcome.

Adverse Event (AE) device related incidenceBaseline to 1 year FU

Incidence, type and severity of all device-related Adverse Events (AEs) at intraoperatively, at discharge, 6 months and 1 year after the implant

Knee injury and Osteoarthritis Outcome Score (KOOS)Baseline to 1 year FU

Changes in the Knee injury and Osteoarthritis Outcome Score (KOOS) from pre-operative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

KOOS is a 42-item self-administered self-explanatory questionnaire that covers five patient-relevant dimensions: Pain, Other Disease-Specific Symptoms, Active Daily Living Function, Sport and Recreation Function, and knee-related Quality of Life. A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems

Forgotten Joint Score (FJS)Baseline to 1 year FU

Changes in the Forgotten Joint Score (FJS) from pre-operative (baseline) to 1 year after the implant of the Physica KR compared to Physica CR designs.

It comprises measures for the assessment of joint-specific patient-reported outcome and focus on patients' awareness of a specific joint in everyday life. It consists of 12 questions and is scored using a 5-point Likert response format (never-almost never-seldom- sometimes-mostly) with the raw scores transformed onto a 0-100 point scale. High scores indicate good outcome.

Radiographic evaluationBaseline to 1 year FU

Radiographic implant evaluation and stability assessment of the Physica KR compared to Physica CR designs at baseline and 1 year after the implant.

Trial Locations

Locations (1)

The Royal Bournemouth Hospital

🇬🇧

Bournemouth, Dorset, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath